Day One Biopharmaceuticals, Inc.
DAWN
23 insider filings · Latest: Apr 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Feb 18 11:02 PM | JEREMY BENDER | Proposed Sale | 12,048 | $11.96 | $144.1K | — | View → |
| Nov 18, 2024 | Nov 18 9:22 PM | SAMUEL BLACKMAN | Proposed Sale | 2,206 | $13.21 | $29.1K | — | View → |
| Nov 18, 2024 | Nov 18 9:21 PM | JEREMY BENDER | Proposed Sale | 10,554 | $13.21 | $139.4K | — | View → |
| Nov 11, 2024 | Nov 12 12:49 PM | SAMUEL BLACKMAN | Proposed Sale | 50,000 | $16.39 | $819.5K | — | View → |
| Oct 31, 2024 | Oct 31 8:27 PM | SAMUEL BLACKMAN | Proposed Sale | 30,000 | $14.47 | $434.1K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Jan 30 10:17 PM | Jeremy BenderDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 592,000 | $11.16 | 237,000(D) | View → |
| Jan 30, 2026 | Jan 30 10:16 PM | Lauren MerendinoChief Commercial Officer | Grant/Award | 184,000 | $11.16 | 74,000(D) | View → |
| Jan 30, 2026 | Jan 30 10:15 PM | Adam DubowGen Counsel & Secretary | Grant/Award | 175,000 | $11.16 | 70,000(D) | View → |
← Previous
Page 2 of 2